May 16, 2019 / 5:08 AM / 4 days ago

BRIEF-Roche Says Entrectinib Shrank Tumours Harbouring NTRK, ROS1 Or ALK Gene Fusions In Children And Adolescents

May 16 (Reuters) - Roche Holding AG:

* SAYS ITS PERSONALISED MEDICINE ENTRECTINIB SHRANK TUMOURS HARBOURING NTRK, ROS1 OR ALK GENE FUSIONS IN CHILDREN AND ADOLESCENTS Source text for Eikon: Further company coverage: (Reporting By Zurich newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below